KDM3A and cancer: Consequently, JMJD1A’s impact on histone methylation and chromatin dynamics highlights its potential as a therapeutic target for both cancer and neurodegenerative conditions, offering avenues for interventions aimed at restoring normal gene expression and cellular function.